Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1472 results

Align for the future with next-generation balloon expandable THV technology

15 May 2024 – From EuroPCR 2024

In this session, explore the next-generation balloon-expandable Myval Octacor THV, focusing on its key features, procedural impact, and potential clinical benefits. Understand the procedural steps for planning and implanting it, especially for intermediate and extra-large sizes, using the Octalign technique. Learn about the unmet clinical need...

Align for the future with next-generation balloon expandable transcatheter heart valve technology

Major Late-Breaking Trials from EuroPCR 2024

15 May 2024 – From EuroPCR 2024

This session presents the latest results from major late-breaking trials presented at EuroPCR 2024. It covers a one-month DAPT followed by 5-month ticagrelor monotherapy in acute coronary syndromes with DCB, the first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid...

Major Late-Breaking Trials from EuroPCR 2024

Aortic valve-in-valve or TAV-in-TAV challenges

15 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the challenges of aortic valve-in-valve or TAV-in-TAV procedures. The session will feature various complex cases, including when even two surgeries are not enough, resilient rhythms in geriatric resurgence, valve-in-valve TAVI for degenerated small surgical bioprosthetic...

Aortic valve-in-valve or TAV-in-TAV challenges

Management of multiple valve disease

15 May 2024 – From EuroPCR 2024

Management of multiple valve disease

EuroPCR 2024 – Short-term data from NOTION-2: TAVR versus SAVI for younger patients with aortic stenosis

15 May 2024

Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice....

TAVI updates: expanding indications

14 May 2024 – From EuroPCR 2024

This session presents the latest updates and evidence on the expanding indications for transcatheter aortic valve implantation (TAVI). It covers topics such as the impact of unfavorable aortic valve anatomy on TAVI outcomes, sex-specific differences in cardiac damage in aortic stenosis patients undergoing TAVI, the use...

TAVI updates: expanding indications

Crossing the finishing line - Latest best practices and technologies for large hole arterial and venous closure

14 May 2024 – From EuroPCR 2024

Tune in to this session for insights on optimizing vascular access and closure techniques. Explore steps like thorough CT analysis, ultrasound-guided puncture, and contingency plans for alternative access methods to minimize complications. Discover a novel patch-based closure approach offering immediate hemostasis and simplified usage, addressing issues...

Crossing the finishing line - Latest best practices and technologies for large hole arterial and venous closure

Case closed: understanding the steps of vascular access and closure in TAVI patients

14 May 2024 – From EuroPCR 2024

Join this session to gain comprehensive insights on combining CT and echo guidance for optimal vascular access. Learn detailed steps for vascular closure using suture-mediated devices and explore the challenges and solutions associated with achieving successful suture-mediated vessel closure. This session will provide valuable knowledge and...

Case closed: understanding the steps of vascular access and closure in TAVI patients

TAVI in TAVI - LIVE case

14 May 2024 – From EuroPCR 2024

A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...

TAVI for degenerated aortic bioprosthesis

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

14 May 2024 – From EuroPCR 2024

Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

How to overcome the most clinically relevant challenges in TAVI

14 May 2024 – From EuroPCR 2024

Watch this session to discover insights into patient-prosthesis mismatch and strategies to mitigate risks, delve into the significance of aortic valve commissure for coronary alignment optimization during TAVI, and explore solutions for common TAVI challenges such as peripheral vessel tortuosity and asymmetric valve calcifications in large...

How to overcome the most clinically relevant challenges in TAVI

Align for the future with next-generation balloon expandable transcatheter heart valve technology

14 May 2024 – From EuroPCR 2024

Tune in to this EuroPCR 2024 session to explore the Myval Octacor THV, a cutting-edge balloon-expandable transcatheter heart valve. Discover its advanced features, potential clinical benefits, and procedural impact. Learn about the latest updates on the Myval THV series and the LANDMARK RCT. Explore the OctaAlign technique for...

Align for the future with next-generation balloon expandable transcatheter heart valve technology

Late-breaking trials: TAVI head-to-head

14 May 2024 – From EuroPCR 2024

This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...

Late-breaking trials: TAVI head-to-head

Critical aortic stenosis: what would you choose?

14 May 2024 – From EuroPCR 2024

This session, in collaboration with the GACI (French Group of Atheroma and Interventional Cardiology), Norwegian Working Group on Interventional Cardiology, and Dutch Working Group on Interventional Cardiology, presents three challenging cases of critical aortic stenosis. The cases include a patient with bicuspid aortic stenosis, a pregnant...

Critical aortic stenosis: what would you choose?

TAVI in bicuspid stenosis: complex situations

14 May 2024 – From EuroPCR 2024

This session comprises selected clinical case submissions focused on TAVI (Transcatheter Aortic Valve Implantation) in patients with bicuspid aortic stenosis. Participants will learn about complex scenarios, including fusion raphe, hostile bicuspid anatomy, large annulus, and early TAVR dysfunction. The session features case presentations followed by audience...

TAVI in bicuspid stenosis: complex situations

Percutaneous valvular interventions and cardiogenic shock

14 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions focused on percutaneous valvular interventions in the context of cardiogenic shock. Learn about complex cases, including severe aortic stenosis with cardiogenic shock, transcatheter treatment of acute heart failure due to surgical prosthetic valve, and acute management of post-AMI papillary...

Percutaneous valvular interventions and cardiogenic shock

TAVI in challenging anatomies

14 May 2024 – From EuroPCR 2024

Explore the complexities of TAVI in patients with intricate aortic stenosis: learn the critical role of detailed CT imaging and meticulous pre-procedural planning, and find out how to customize valve selection and implantation techniques to match unique patient anatomies, such as highly calcified tricuspid valves, low...

TAVI in challenging anatomies

How will the SMART trial results impact our practice and decision making in TAVI?

16 May 2024 – From EuroPCR 2024

Sabine Bleiziffer and Didier Tchétché discuss the SMART trial with Flavio Ribichini in this #europcr 2024 roundtable. The trial compares the self-expandable supra-annular EVOLUT platform and the balloon-expandable intra-annular SAPIEN platform in patients with small aortic annulus, prevalent in up to 40% of Europeans, mainly women....

How will the SMART trial results impact our practice and decision making in TAVI?

Sensor-Guided TAVI using the SavvyWire Pre-Shaped Pressure Guidewire

16 May 2024 – From EuroPCR 2024

In this roundtable discussion, Ole De Backer and Danny Dvir explore the potential of the new SavvyWire to enhance #TAVI procedures by improving safety and efficiency while reducing the need for multiple manipulations. They also highlight how real-time left ventricle monitoring during procedures can lead to...

Sensor-Guided TAVI using the SavvyWire Pre-Shaped Pressure Guidewire

Clinical experience with DurAVR THV: a new class, biomimetic TAVI

16 May 2024 – From EuroPCR 2024

Join Azeem Latib, Christopher Meduri, and Nicolas Van Mieghem as they explore the history of cutting-edge tissue science in the TAVI space. Learn about the development of a biomimetic aortic valve design and insights from the DurAVR FIH study on this balloon-expandable platform. Discover the link...

Clinical experience with DurAVR THV: a new class, biomimetic TAVI